Market Overview

UPDATE: Credit Suisse Downgrades Stryker Corporation to Neutral on Valuation

Related SYK
Morgan Stanley Remains Positive On Stryker Corporation
Morgan Stanley Has Critical Questions For Stryker Corporation Going Into Investor Day

Credit Suisse downgraded Stryker Corporation (NYSE: SYK) from Outperform to Neutral.

Credit Suisse said, "We're downgrading SYK to Neutral from Outperform following the stock's recent strong performance, which leaves < 10% upside relative to our unchanged $67 price target. We continue to like SYK's diversified business model, strong FCF generation ability & solid long-term sales growth profile, and do not see SYK shares as particularly expensive (currently trades at 13.3X our 2014 estimate, slightly below the last 5-year average of 13.9X); however, we believe further mid-term valuation / EPS upside is likely to require developments not incorporated in our current forecasts such as above trend-line WW hip/knee market performance, rapid and dramatic improvement in OUS hip/knee execution, &/or added M&A, perhaps in the emerging markets."

Stryker Corporation closed at $63.06 on Wednesday.

Latest Ratings for SYK

DateFirmActionFromTo
Aug 2014NeedhamUpgradesBuy
Jul 2014CitigroupMaintainsNeutral
Jul 2014BarclaysMaintainsEqual-weight

View More Analyst Ratings for SYK
View the Latest Analyst Ratings

Posted-In: Credit SuisseAnalyst Color Downgrades Analyst Ratings

 

Related Articles (SYK)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters